The administration wants to “bring copper production home” but the most likely result is that American manufacturers will have little choice but to pay more for it.
Another day, another tariff threat from Donald Trump.
The immediate political focus in Canberra is on the risk to Australia’s pharmaceuticals industry, given concerns the Trump administration will also target Australia’s pharmaceutical benefits scheme.
Loading...
Jennifer Hewett is the national affairs columnist. She writes a daily column on politics, business and the economy. Connect with Jennifer on Twitter. Email Jennifer at jennifer.hewett@afr.com